Amgen USA Inc.
Thousand Oaks, CA Part of Amgen Inc.
- UEI
- XPGNQMXHP493
- CAGE
- 5YNZ4
- Primary NAICS
- 325412 Pharmaceutical Preparation Manufacturing
- SAM.gov registration
- Active through
Company facts
- FY2025 rankings
- Self-certified in SAM.gov
- Entity structure
- Corporate Entity (Not Tax Exempt)
- Other NAICS codes in SAM.gov
- Corporate family
-
-
Parent
Thousand Oaks, CA
D92HARF1LKA9
-
Parent
Thousand Oaks, CA
D92HARF1LKA9
- SAM.gov registration date
- Physical address
- 1 Amgen Center Dr, Thousand Oaks, CA 91320, USA
- Website
- amgen.com
- Founded
- 1980
- Employees
- 10K-50K
- Estimated annual revenue
- $10B+
- Industry
-
- Health Care
- Pharmaceuticals, Biotechnology & Life Sciences
- Pharmaceuticals
- SIC code
- 28 Chemical & Allied Products
- Profiles
Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated .
Contract obligations by fiscal year
| Fiscal year | Obligated |
|---|---|
| FY2027 To date | $0 |
| FY2026 | $125,985,024 |
| FY2025 | $89,869,429 |
| FY2024 | $129,979,386 |
| FY2023 | $204,974,392 |
Top agencies by obligations
| Rank | Agency | Obligated, FY2026–FY2027 | Share |
|---|---|---|---|
| 1 | Department of Health and Human Services | $125,985,024 |
Contract vehicles
Expired vehicles (1)
Contract awards
Latest 5 listed here. See the rest on GovTribe.
Similar vendors
| Vendor | Location | Primary NAICS |
|---|---|---|
| U.s. Division | Rockville, MD | 424210 Drugs and Druggists' Sundries Merchant Wholesalers |
| Organon & Co Of Delaware, Inc. | Jersey City, NJ | 325412 Pharmaceutical Preparation Manufacturing |
| Cardinal Health, Inc. | — | — |
| Endo Usa, Inc. | Malvern, PA | 325412 Pharmaceutical Preparation Manufacturing |
| Exela Pharma Sciences LLC | Lenoir, NC | 325412 Pharmaceutical Preparation Manufacturing |
About the company
Amgen USA Inc., Amgen USA Division, is a registered federal contractor providing pharmaceutical products and services to various government agencies. As a division of Amgen Inc., a leading biotechnology company, Amgen USA specializes in developing innovative therapies for serious illnesses. The company has been actively engaged in federal contracting since its registration in SAM.gov on April 2, 2010, with its current registration valid until April 2, 2025. Amgen USA is structured as a for-profit corporate entity and is classified as a manufacturer of goods.
Amgen USA has secured several significant federal contract awards in recent years, primarily in the healthcare and pharmaceutical sectors. A major contract awarded by the Department of Health and Human Services' Office of the Assistant Secretary for Preparedness and Response involves the provision of vendor managed inventory services for 165,906 doses of Neulasta, a drug used to mitigate injuries from chemical, biological, radiological, nuclear, and physical threats. Another substantial award from the same agency, valued at over $1 billion, is for the delivery of an FDA-approved thrombopoietin receptor agonist to treat thrombocytopenia resulting from acute radiation syndrome. The company has also received contracts from the Department of Veterans Affairs for supplying pharmaceuticals such as TAVNEOS (AVACOPAN) and influenza vaccines. Additionally, Amgen USA has provided flu shots to staff at federal correctional facilities under contracts with the Department of Justice Bureau of Prisons.
Amgen USA holds two significant federal contract IDVs. The first is a Federal Supply Schedule contract (36F79721D0086) awarded by the Department of Veterans Affairs, with a ceiling value of $3.37 billion. This multiple-award vehicle, under the GSA Pharmaceuticals and Drugs (FSS-61-IB) schedule, allows Amgen to supply pharmaceuticals, drugs, and hematology-related products to various federal agencies. The second IDV (36E79720D0006) is a single-award indefinite delivery contract from the VA National Acquisition Center, with a ceiling value of $58.97 million. This contract focuses on supplying calcitonin gene-related peptide agents to the VA, Bureau of Prisons, and Indian Health Service. Under these IDVs, Amgen has received task orders for products such as TAVNEOS and influenza vaccines, demonstrating the company's role in providing critical medical supplies to support federal healthcare initiatives.
Quick answers
Is Amgen USA Inc. registered in SAM.gov?
Yes. Amgen USA Inc.'s SAM.gov registration is active through March 19, 2027.
Which contract vehicles does Amgen USA Inc. hold?
Amgen USA Inc. holds a place on 2 federal contract vehicles, including FSS-61-IB.
How much has Amgen USA Inc. received in federal contracts?
Federal contracts obligated $89,869,429 to Amgen USA Inc. in fiscal year 2025 and $550,808,230 in fiscal years 2023 through 2027.
How does Amgen USA Inc. rank among federal contractors?
Amgen USA Inc. ranked #1 in PSC AN13, #2 in NAICS 541714 and #5 in PSC AN in FY2025.
What is Amgen USA Inc.'s most recent federal award?
Amgen USA Inc.'s most recent federal contract award is Vendor managed inventory (VMI) services for USG procured 165,906 doses of neulasta product to mitigate injuries… (75A50124C00011), from Office of the Assistant Secretary for Preparedness and Response, on March 12, 2024.
On GovTribe
See Amgen USA Inc.'s full federal record
- Federal contract awards
- IDV awards
- Contract vehicles
- Funding analysis by agency, NAICS and set-aside
- Similar vendors